Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention

Circulation

Volumn 110, Issue 3, 2004, Pages 271-277

  McKechnie, Ronald S ^a   Smith, Dean ^a   Montoye, Cecelia ^a   Kline Rogers, Eva ^a   O'Donnell, Michael J ^a   DeFranco, Anthony C ^a   Meengs, William L ^a   McNamara, Richard ^a   McGinnity, John G ^a   Patel, Kirit ^a   Share, David ^a   Riba, Arthur ^a   Khanal, Sanjaya ^a   Moscucci, Mauro ^a,b  

^a BMC2 ^*  (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Anemia; Angioplasty; Mortality

Indexed keywords

HEMOGLOBIN;

ADULT; AGE; AGED; ANEMIA; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; COMORBIDITY; FEMALE; GENDER; HEART INFARCTION; HOSPITAL CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RISK; TREATMENT OUTCOME;

AGED; ANEMIA; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 3242682386     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000134964.01697.C7     Document Type: Article

References (20)

1. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 1999;340:409-417.
2. DeFoe GR, Ross CS, Olmstead EM, et al. Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Ann Thorac Surg. 2001;71:769-776.
3. Czer LS, Shoemaker WC. Optimal hematocrit value in critically ill post-operative patients. Surg Gynecol Obstet. 1978;147:363-368.
4. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes. Circulation. 2003; 107:223-225.
5. Wu WC, Rathore SS, Wang Y, et al. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med. 2001;345:1230-1236.
6. Moscucci M, Kline-Rogers E, Share D, et al. Simple bedside additive tool for prediction of in-hospital mortality after percutaneous coronary interventions. Circulation. 2001;104:263-268.
7. World Health Organization, Nutritional anaemias: report of a WHO scientific group. World Health Organ Tech Rep Ser. 1968;405:33-37.
8. Carson JL, Duff A, Pses RM, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet. 1996;348: 1055-1060.
9. Hebert PC, Wells G, Tweeddale M, et al. Does transfusion practice affect mortality in critically ill patients? Transfusion requirements in critical care (TRICC) investigators and the Canadian Critical Care Trials Group. Am J Respir Crit Care Med. 1997;155:1618-1623.
10. Horwich TB, Fonarow GC, Hamilton MA, et al. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure, J Am Coll Cardiol. 2002;39:1780-1786.
11. Sarnak JM, Tighiouart H, Manjunath G, et al. Anemia as a risk factor for cardiovascular disease in the atherosclerosis risk in communities (ARIC) study. J Am Coll Cardiol. 2002;40:27-33.
12. Most AS, Ruocco NA Jr, Gewirtz H. Effect of a reduction in blood viscosity on maximal myocardial oxygen delivery distal to a moderate coronary stenosis. Circulation. 1986;74:1085-1092.
13. Levy PS, Kim SJ, Eckel PK, et al. Limit to cardiac compensation during acute isovolemic hemodilution: influence of coronary stenosis. Am J Physiol. 1993;265:H340-H349.
14. Kalchthaler T, Tan ME. Anemia in institutionalized elderly patients. J Am Geriatr Soc. 1980;28:108-113.
15. Joosten E, Pelemans W, Hiele M, et al. Prevalence and causes of anemia in a geriatric hospitalized population. Gerontology. 1992;38:111-117.
16. Brown DW, Giles WH, Croft JB. Hematocrit and the risk of coronary heart disease mortality. Am Heart J. 2001;142:657-663.
17. Gagnon DR, Zhang TJ, Brand FN, et al. Hematocrit and the risk of cardiovascular disease: the Framingham study. A 34-year follow-up. Am Heart J. 1994;127:674-682.
18. Corwin HL, Gettinger A, Pearl RG, et al for the EPO Critical Care Trials Group. Efficacy of recombinant human erythropoietin in critically ill patients. JAMA. 2002;288:2827-2835.
19. Blankenship JC. Bleeding complications of glycoprotein IIb-IIIa inhibitors. Am Heart J. 1999;138:S287-S296.
20. Cothren C, Moore EE, Offner PJ, et al. Blood substitute and erythropoietin therapy in a severely injured Jehovah's Witness. N Engl J Med. 2002;346:1097-1098.